PROTHENA CORP PLC (PRTA) Stock News
NASDAQ:PRTA - Nasdaq - IE00B91XRN20 - Common Stock - Currency: USD
PRTA Latest News, Press Relases and Analysis
Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi
Following the nod in the EU, BIIB & Eisai's Leqembi becomes the first therapy to slow the progression of early Alzheimer's disease in the region.
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Prothena Announces Board of Directors Update
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients.
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Prothena Corp (NASDAQ:PRTA) just reported results for the second quarter of 202...
Prothena to Report Third Quarter 2024 Financial Results on November 12
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Prothena Corp (NASDAQ:PRTA) just reported results for the first quarter of 2024...
Prothena Announces Leadership Team Updates
Prothena to Participate in Upcoming Healthcare Conferences
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
Prothena to Report Second Quarter 2024 Financial Results on August 8
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
